|
211 |
Correction to: Ideas, actors and institutions: lessons from South Australian Health in All Policies on what encourages other sectors’ involvement
Enthalten in BMC public health Bd. 17, 8.11.2017, Nr. 1, date:12.2017: 1-3
|
|
|
|
212 |
Correction to: Mental health training for primary health care workers and implication for success of integration of mental health into primary care: evaluation of effect on knowledge, attitude and practices (KAP)
Enthalten in International journal of mental health systems Bd. 11, 10.11.2017, Nr. 1, date:12.2017: 1
|
|
|
|
213 |
Cost effectiveness of etelcalcetide versus cinacalcet in Europe
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 9
|
|
|
|
214 |
Cost effectiveness of genetic testing in CRC uncertain
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 10
|
|
|
|
215 |
Cost effectiveness of PrEP greater in high-risk PWID
Enthalten in PharmacoEconomics & outcomes news Bd. 795, 27.1.2018, Nr. 1, date:1.2018: 8
|
|
|
|
216 |
Counting the costs of severe maternal morbidity
Enthalten in PharmacoEconomics & outcomes news Bd. 795, 27.1.2018, Nr. 1, date:1.2018: 9
|
|
|
|
217 |
Current situations and future directions for mental health system governance in Nepal: findings from a qualitative study
Enthalten in International journal of mental health systems Bd. 11, 8.6.2017, Nr. 1, date:12.2017: 1-12
|
|
|
|
218 |
Current UK Practices on Health Economics Analysis Plans (HEAPs): Are We Using Heaps of Them?
Enthalten in PharmacoEconomics Bd. 36, 6.12.2017, Nr. 2, date:2.2018: 253-257
|
|
|
|
219 |
DAAs cost effective for treatment of hepatitis C in Norway
Enthalten in PharmacoEconomics & outcomes news Bd. 796, 10.2.2018, Nr. 1, date:2.2018: 11
|
|
|
|
220 |
Daratumumab, panobinostat cost effective for MM
Enthalten in PharmacoEconomics & outcomes news Bd. 795, 27.1.2018, Nr. 1, date:1.2018: 10
|
|
Administration
